Carlson College of Veterinary Medicine

B. W. Neuman, Stein, D. A., Kroeker, A. D., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J., “Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.”, Advances in experimental medicine and biology, vol. 581, pp. 567-71, 2006.

B. W. Neuman, Stein, D. A., Kroeker, A. D., Churchill, M. J., Kim, A. M., Kuhn, P., Dawson, P., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J., “Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers.”, Journal of virology, vol. 79, no. 15, pp. 9665-76, 2005.

J. Yuan, Stein, D. A., Lim, T., Qiu, D., Coughlin, S., Liu, Z., Wang, Y., Blouch, R., Moulton, H. M., Iversen, P. L., and Yang, D., “Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.”, Journal of virology, vol. 80, no. 23, pp. 11510-9, 2006.

T. S. Deas, Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D. A., Moulton, H. M., Iversen, P. L., Kauffman, E. B., Kramer, L. D., and Shi, P. Y., “Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.”, J Virol, vol. 79, no. 8, pp. 4599-609, 2005.

B. L. Geller, Deere, J. D., Stein, D. A., Kroeker, A. D., Moulton, H. M., and Iversen, P. L., “Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.”, Antimicrobial agents and chemotherapy, vol. 47, no. 10, pp. 3233-9, 2003.

M. Moerdyk-Schauwecker, Stein, D. A., Eide, K., Blouch, R. E., Bildfell, R. J., Iversen, P., and Jin, L., “Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27.”, Antiviral research, vol. 84, no. 2, pp. 131-41, 2009.

M. Alonso, Stein, D. A., Thomann, E., Moulton, H. M., Leong, J. C., Iversen, P., and Mourich, D. V., “Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.”, Journal of fish diseases, vol. 28, no. 7, pp. 399-410, 2005.

C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M., “Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”, Archives of virology, vol. 153, no. 5, pp. 929-37, 2008.

Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A., “Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”, Antimicrobial agents and chemotherapy, vol. 50, no. 11, pp. 3724-33, 2006.

Y. - J. Zhang, Wang, K. - Y., Stein, D. A., Patel, D., Watkins, R., Moulton, H. M., Iversen, P. L., and Matson, D. O., “Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.”, Antiviral research, vol. 73, no. 1, pp. 12-23, 2007.

B. P. Dolan, Phelan, T. P., Ilkovitch, D., Qi, L., Wade, W. F., Laufer, T. M., and Ostrand-Rosenberg, S., “Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.”, Journal of immunology (Baltimore, Md. : 1950), vol. 172, no. 2, pp. 907-14, 2004.

L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., “Isolation of two subpopulations of Mycobacterium avium within human macrophages.”, FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.

M. R. Sarker, Sory, M. P., Boyd, A. P., Iriarte, M., and Cornelis, G. R., “LcrG is required for efficient translocation of Yersinia Yop effector proteins into eukaryotic cells.”, Infection and immunity, vol. 66, no. 6, pp. 2976-9, 1998.

J. E. Ishmael, Löhr, C. V., Fischer, K. A., and Kioussi, C., “Localization of myosin II regulatory light chain in the cerebral vasculature.”, Acta histochemica, vol. 110, no. 2, pp. 172-7, 2008.

D. J. Coleman, Chagani, S., Hyter, S., Sherman, A. M., Löhr, C. V., Liang, X., Ganguli-Indra, G., and Indra, A. K., “Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.”, Mol Cancer Res, vol. 13, no. 1, pp. 186-96, 2015.

W. Wang, Gordon, J. L., Philbrick, K. A., Yang, X., Branscum, A. J., Löhr, C. V., Haschek, W. M., Turner, R. T., Iwaniec, U. T., and Helferich, W. G., “Low calcium diet increases 4T1 mammary tumor carcinoma cell burden and bone pathology in mice.”, PLoS One, vol. 12, no. 7, p. e0180886, 2017.

A. Kumar Indra, Castaneda, E., Antal, M. Cristina, Jiang, M., Messaddeq, N., Meng, X., Löhr, C. V., Gariglio, P., Kato, S., Wahli, W., Desvergne, B., Metzger, D., and Chambon, P., “Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.”, The Journal of investigative dermatology, vol. 127, no. 5, pp. 1250-60, 2007.

L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.

P. L. Iversen, Mourich, D. V., and Moulton, H. M., “Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer.”, Current opinion in molecular therapeutics, vol. 5, no. 2, pp. 156-60, 2003.

S. Fletcher, Honeyman, K., Fall, A. M., Harding, P. L., Johnsen, R. D., Steinhaus, J. P., Moulton, H. M., Iversen, P. L., and Wilton, S. D., “Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse.”, Molecular therapy : the journal of the American Society of Gene Therapy, vol. 15, no. 9, pp. 1587-92, 2007.

J. L. Traub-Dargatz, Schlipf, J. W., Granstrom, D. E., Ingram, J. T., Shelton, G. D., Getzy, D. M., Lappin, M. R., and Baker, D. C., “Multifocal myositis associated with Sarcocystis sp in a horse.”, Journal of the American Veterinary Medical Association, vol. 205, no. 11, pp. 1574-6, 1994.

L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Mycobacteria and AIDS: treatment, prevention and future prospects.”, Research in microbiology, vol. 143, no. 4, pp. 420-2, 1992.

C. B. Inderlied, Kemper, C. A., and Bermudez, L. E., “The Mycobacterium avium complex.”, Clinical microbiology reviews, vol. 6, no. 3, pp. 266-310, 1993.

L. E. Bermudez, Inderlied, C. B., and Young, L. S., “Mycobacterium avium complex in AIDS.”, Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.